Brazil-Italy joint lab focuses on Alzheimer’s drug development
A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology ...
Tag: Hematology
UC's Eric Vick receives major grants to advance research into combination therapy for leukemia
The University of Cincinnati Cancer Center's Eric Vick, MD, PhD, has been awarded a nearly $215,000 Career Development Award from ...
CD5 knockout using CRISPR boosts CAR T cell therapy efficacy
The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by ...
Evolving treatment paradigms in multiple myeloma could improve patient outcomes
The , the second most common blood cancer, is shifting rapidly, with newly diagnosed patients increasingly being treated with a ...
New stem cell transplant approach may expand donor pool for high-risk blood cancer patients
A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem ...
City of Hope cures oldest person of blood cancer and achieves HIV remission
City of Hope®, one of the largest cancer research and treatment organizations in the United States, treated the oldest person ...
Study: Two-thirds of babies with sickle cell disease are born to mothers living in disadvantaged areas
As if starting life with a potentially disabling genetic blood disease wasn't enough, a study shows that almost two-thirds of ...
Common oral anticoagulant rivaroxaban linked to highest risk of bleeding complications
When diagnosed with a blood clot or atrial fibrillation, patients are often prescribed anticoagulants, or blood thinners, to prevent a ...
New combination treatment offers hope for older patients with mantle cell lymphoma
The phase 2 trial PrE0405 met its primary endpoint, achieving a complete response (CR) rate of 85% in 33 patients ...
Study could pave the way for synergistic therapeutic combinations to better treat SF3B1-mutant MDS
A new study from researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and ...
